便秘治療市場規模、佔有率和成長分析（按治療方法、給藥途徑、患者類型、通路和地區分類）—2026-2033年行業預測

全球便秘治療市場規模預計在 2024 年達到 193.1 億美元，從 2025 年的 204.9 億美元成長到 2033 年的 329 億美元，在預測期（2026-2033 年）內複合年成長率為 6.1%。

全球便秘治療市場正經歷顯著成長，這主要得益於幾個關鍵因素。人口老化導致慢性便秘和胃腸道疾病的盛行率上升，而鴉片類藥物使用量的增加又導致鴉片類藥物引起的便秘病例激增，從而推動了對標靶治療方法的需求。消費者擴大轉向非處方天然產品，這一趨勢也得益於人們對腸道健康的日益關注。此外，數位健康管理和遠距醫療等技術的進步提高了診斷和治療水平，進一步推動了市場發展。然而，挑戰依然存在，包括瀉藥副作用導致的患者依從性問題、經濟低度開發地區認知度低、治療費用高昂以及監管障礙導致產品上市延遲等，這些都為現有企業和新參與企業創造了複雜的市場環境。

推動全球便秘治療市場發展的因素

大腸激躁症和慢性特發性便秘等胃腸道疾病的日益普遍是便秘治療市場的主要驅動力。造成這現象的因素包括久坐的生活方式、不良的飲食習慣以及人口老化。這些因素共同導致便秘相關疾病的發生率上升，並推動了對處方藥和非處方藥的需求。人們對這些疾病的認知不斷提高，加上健康促進意識的增強，預計將確保對有效便秘治療的需求保持強勁，從而推動市場的進一步發展和創新。

限制全球便秘治療市場的因素

全球便秘治療市場面臨長期使用瀉藥和某些處方藥的挑戰，這些藥物常常會引起成癮、電解質失衡和胃腸道不適等副作用，從而降低患者對治療方案的依從性，並阻礙長期管理策略的整體療效。這種情況促使人們轉向更容易接受且更安全的便秘治療方法，同時也推動了非藥物療法的研發和應用。因此，醫療保健專業人員面臨越來越大的壓力，需要探索並優先選擇治療方法。

全球便秘治療市場趨勢

在全球便秘治療市場，個人化腸道健康解決方案正日益普及，這主要得益於微生物組研究和人工智慧技術的進步。這一趨勢反映出治療方式正發生重大轉變，即更加重視個體化的治療方案，以應對個別腸道菌叢、生活方式因素以及持續的症狀追蹤。針對特定患者需求量身定做的干涉措施旨在提高治療效果、增強患者依從性並改善整體治療結果。隨著科技在醫療保健領域的日益融合，個人化治療的興起代表著便秘管理領域的一個變革性方向，與整個醫療保健領域以患者為中心的護理和精準醫療的更廣泛趨勢相契合。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

全球便秘治療市場規模（依治療方法分類）及複合年成長率（2026-2033 年）

• 藥理學
  • 瀉藥
  • 氯離子通道活化劑
  • GC-C促效劑
  • 5-HT4促效劑
  • 周邊作用的μ-鴉片受體拮抗劑
  • 其他
• 非藥物療法
  • 膳食纖維補充劑
  • 生物回饋療法和物理療法
  • 糞便微生物移植
  • 數位療法

全球便秘治療市場規模（依給藥途徑及複合年成長率分類）（2026-2033 年）

• 口服
• 直腸給藥
• 腸外/皮下給藥

全球便秘治療市場規模（依病患類型分類）及複合年成長率（2026-2033 年）

• 成人
• 兒童
• 老年人

全球便秘治療市場規模（依分銷管道分類）及複合年成長率（2026-2033 年）

• 醫院藥房
• 零售藥局和藥局
• 網路藥房

全球便秘治療市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• AbbVie Inc.（United States）
• Takeda Pharmaceutical Company（Japan）
• Bausch Health Companies Inc.（Canada）
• Ironwood Pharmaceuticals（United States）
• Sanofi（France）
• Bayer（Germany）
• GlaxoSmithKline（United Kingdom）
• Johnson & Johnson（United States）
• Procter & Gamble（United States）
• Shionogi & Co., Ltd.（Japan）
• Cipla（India）
• AstraZeneca（United Kingdom）
• Boehringer Ingelheim GmbH（Germany）
• Prestige Consumer Healthcare Inc.（United States）
• Nestle Health Science（Switzerland）
• Ardelyx Inc.（United States）
• Mallinckrodt Pharmaceuticals（Ireland）
• Sun Pharmaceutical Industries Ltd.（India）
• Cosmo Pharmaceuticals（Ireland）
• CB Fleet Company Inc.（United States）

結論與建議

Global Constipation Treatment Market size was valued at USD 19.31 Billion in 2024 and is poised to grow from USD 20.49 Billion in 2025 to USD 32.9 Billion by 2033, growing at a CAGR of 6.1% during the forecast period (2026-2033).

The global constipation treatment market is experiencing significant growth driven by several key factors. An aging population has led to an increased prevalence of chronic constipation and gastrointestinal disorders, while a rise in opioid usage has resulted in a surge of opioid-induced constipation cases, escalating the need for targeted treatments. Consumers are increasingly favoring over-the-counter natural products, a trend supported by heightened awareness of gut health. Additionally, advancements in technology, such as digital health tracking and teleconsultation, are improving diagnosis and management, further fueling market momentum. However, challenges persist, including patient compliance issues due to laxative side effects, low awareness in economically disadvantaged areas, high therapy costs, and regulatory hurdles that slow product launches, complicating the landscape for both established companies and new entrants.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Constipation Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Constipation Treatment Market Segments Analysis

Global Constipation Treatment Market is segmented by Treatment Type, Route of Administration, Patient Type, Distribution Channel and region. Based on Treatment Type, the market is segmented into Pharmacological and Non-Pharmacological. Based on Route of Administration, the market is segmented into Oral, Rectal and Parenteral / Sub-cutaneous. Based on Patient Type, the market is segmented into Adults, Pediatrics and Geriatrics. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies & Drug Stores and Online Pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Constipation Treatment Market

The rising prevalence of gastrointestinal disorders, such as irritable bowel syndrome and chronic idiopathic constipation, significantly propels the growth of the constipation treatment market. Contributing factors include sedentary lifestyles, poor dietary choices, and an increasingly aging demographic. These elements combine to create a higher incidence of constipation-related issues, which in turn fuels the demand for both prescription and over-the-counter treatment options. As awareness of these conditions grows, coupled with a focus on improved health and wellness, it is anticipated that the need for effective constipation treatments will remain robust, driving further developments and innovations within the market.

Restraints in the Global Constipation Treatment Market

The Global Constipation Treatment market faces challenges due to the prolonged use of laxatives and certain prescription medications, which often lead to adverse effects such as dependency, electrolyte imbalances, and gastrointestinal discomfort. These complications tend to reduce patient adherence to treatment regimens, inhibiting the overall effectiveness of long-term management strategies. Consequently, this situation is prompting a shift toward more acceptable and safer alternatives in constipation care, while simultaneously fostering the development and adoption of non-pharmacological therapies. As a result, healthcare providers are increasingly encouraged to explore and prioritize treatment options that minimize potential side effects and enhance patient well-being.

Market Trends of the Global Constipation Treatment Market

The Global Constipation Treatment market is increasingly embracing personalized gut health solutions, driven by advancements in microbiome research and artificial intelligence. This trend reflects a significant shift toward customized treatment options that cater to individual gut profiles, lifestyle factors, and ongoing symptom tracking. By tailoring interventions to meet specific patient needs, the market aims to enhance treatment efficacy and boost patient adherence, thereby improving overall outcomes. As technology continues to integrate into healthcare, the emphasis on personalization signifies a transformative direction in constipation management, aligning with broader trends in patient-centered care and precision medicine within the healthcare landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Constipation Treatment Market Size by Treatment Type & CAGR (2026-2033)

• Market Overview
• Pharmacological
  • Laxatives
  • Chloride Channel Activators
  • GC-C Agonists
  • 5-HT4 Agonists
  • Peripherally Acting µ-Opioid Receptor Antagonists
  • Others
• Non-Pharmacological
  • Dietary Fiber Supplements
  • Biofeedback & Physical Therapy
  • Fecal Microbiota Transplant
  • Digital Therapeutics

Global Constipation Treatment Market Size by Route of Administration & CAGR (2026-2033)

• Market Overview
• Oral
• Rectal
• Parenteral / Sub-cutaneous

Global Constipation Treatment Market Size by Patient Type & CAGR (2026-2033)

• Market Overview
• Adults
• Pediatrics
• Geriatrics

Global Constipation Treatment Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies & Drug Stores
• Online Pharmacies

Global Constipation Treatment Market Size & CAGR (2026-2033)

• North America (Treatment Type, Route of Administration, Patient Type, Distribution Channel)
  • US
  • Canada
• Europe (Treatment Type, Route of Administration, Patient Type, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Treatment Type, Route of Administration, Patient Type, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Treatment Type, Route of Administration, Patient Type, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Treatment Type, Route of Administration, Patient Type, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• AbbVie Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bausch Health Companies Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ironwood Pharmaceuticals (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Procter & Gamble (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shionogi & Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cipla (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Prestige Consumer Healthcare Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nestle Health Science (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ardelyx Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mallinckrodt Pharmaceuticals (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cosmo Pharmaceuticals (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• C.B. Fleet Company Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations